GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.681 27 days ( 68.66 % )
Last Price $1.86 1.09 %
High/ Low $1.82 - $1.97 -0.285%
Chg 7 Days -7.46 % $2.01 $1.86
Chg 30 Days -27.34 % $2.56 $1.86
Chg 12 mos -86.08 % $13.36 $1.86
Trend - 3 mos -55.61 % Width: 143.26 %
Trend - 12 mos -48.94 % Width: 276.07 %
Pred. range - 3 mos $0.779 - $1.89 -58.14 % - 1.82 %
Pred. range - 12 mos $0.93 - $3.48 -50.20 % - 87.27 %
Short MA avg 3 mos Sell 2024-04-01 - 13 days
Long MA avg 3 mos Sell 2024-03-08 - 28 days
Short/Long MA avg 3 mos Sell 2024-03-12 - 26 days
Short MA avg 12 mos Sell 2024-03-08 - 28 days
Long MA avg 12 mos Sell 2024-03-08 - 28 days
Short/Long MA avg 12 mos Sell 2024-01-05 - 71 days
Pivot Short Buy 2024-04-16 - 2 days
Bollinger Buy 2024-03-14 - 24 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Immuneering Corporation

Immuneering Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed ... IMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT